Edris Badreddin
Insider CIK 1786966 · EWTX Director · SWTX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-06-05 | 2026-06-16 | 5,619 | — | $0 | 5,619 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-06-05 | 2026-06-16 | 8,188 | — | $0 | 8,188 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 10,463 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 7,605 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 17,236 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 13,690 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 66,477 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-01-21 | 2026-01-23 | 7,605 | $29.44 | $223.9K | 96,760 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-01-21 | 2026-01-23 | 17,236 | $29.44 | $507.4K | 104,365 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-01-21 | 2026-01-23 | 10,463 | $29.44 | $308.0K | 86,297 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-01-21 | 2026-01-23 | 66,477 | $29.44 | $1.96M | 19,820 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 66,477 | $1.93 | $128.3K | 127,686 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 13,690 | $0.39 | $5.3K | 33,510 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 17,236 | $0.64 | $11.0K | 50,746 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 10,463 | $1.93 | $20.2K | 61,209 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 7,605 | $0.71 | $5.4K | 135,291 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-01-21 | 2026-01-23 | 13,690 | $29.44 | $403.0K | 121,601 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 240,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 33,778 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 3,868 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 78,960 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 120,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 149,470 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 169,712 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-06-16 | 2025-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 400 | $56.20 | $22.5K | 169,712 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 3,924 | $53.12 | $208.4K | 185,788 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 12,078 | $54.26 | $655.4K | 173,710 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 3,598 | $55.12 | $198.3K | 170,112 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-10 | 2025-02-12 | 30,000 | $53.13 | $1.59M | 189,712 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2025-01-10 | 2025-01-14 | 78,960 | — | $0 | 78,960 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-01-10 | 2025-01-14 | 27,023 | — | $0 | 219,712 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-06 | 2025-01-07 | 4,416 | $38.86 | $171.6K | 192,689 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-05 | 2025-01-07 | 5,561 | $38.19 | $212.4K | 197,105 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-04 | 2025-01-07 | 6,934 | $38.19 | $264.8K | 202,666 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-12-03 | 2024-12-05 | 11,966 | $41.78 | $499.9K | 217,634 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-12-03 | 2024-12-05 | 8,034 | $42.24 | $339.4K | 209,600 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-09-03 | 2024-09-04 | 4,620 | $41.12 | $190.0K | 232,680 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-09-03 | 2024-09-04 | 12,300 | $40.11 | $493.4K | 237,300 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-09-03 | 2024-09-04 | 3,080 | $42.08 | $129.6K | 229,600 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-06-10 | 2024-06-12 | 20,594 | — | $0 | 20,594 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 11,772 | $39.40 | $463.8K | 257,828 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 4,192 | $40.62 | $170.3K | 253,636 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 3,651 | $41.38 | $151.1K | 249,985 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 385 | $42.04 | $16.2K | 249,600 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-01-08 | 2024-01-08 | 5,466 | $41.53 | $227.0K | 269,600 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-01-05 | 2024-01-08 | 4,469 | $37.96 | $169.6K | 275,066 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-01-04 | 2024-01-08 | 120,000 | — | $0 | 120,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-01-04 | 2024-01-08 | 42,312 | — | $0 | 279,535 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 22,123 | — | $0 | 22,123 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2023-01-07 | 2023-01-10 | 1,483 | $26.41 | $39.2K | 237,223 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2023-01-06 | 2023-01-09 | 3,326 | $27.52 | $91.5K | 238,706 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-01-05 | 2023-01-09 | 135,000 | — | $0 | 135,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-01-05 | 2023-01-09 | 105,000 | — | $0 | 105,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-01-05 | 2023-01-09 | 33,994 | — | $0 | 242,032 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-06-24 | 2022-06-28 | 42,087 | — | $0 | 42,087 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-01-07 | 2022-01-11 | 2,531 | $56.06 | $141.9K | 325,134 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-01-07 | 2022-01-14 | 1,852 | $56.06 | $103.8K | 325,813 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-01-06 | 2022-01-10 | 81,420 | — | $0 | 81,420 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-01-06 | 2022-01-10 | 26,124 | — | $0 | 327,665 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-07-01 | 2021-07-01 | 32,000 | $85.35 | $2.73M | 301,541 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-01-25 | 2021-01-26 | 32,000 | $84.07 | $2.69M | 261,542 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-01-07 | 2021-01-11 | 104,000 | — | $0 | 104,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-01-07 | 2021-01-11 | 13,000 | — | $0 | 293,542 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-03-02 | 2020-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |